home / stock / vtgn / vtgn news

VTGN News and Press, VistaGen Therapeutics Inc. From 09/05/23

Stock Information
Company Name: VistaGen Therapeutics Inc.
Stock Symbol: VTGN
Market: NASDAQ
Website: vistagen.com
Menu
VTGN VTGN Quote VTGN Short VTGN News VTGN Articles VTGN Message Board
Get VTGN Alerts

News, Short Squeeze, Breakout and More Instantly...
VTGN - InvestorNewsBreaks - VistaGen Therapeutics Inc. (NASDAQ: VTGN), Fuji Pharma Co. Ltd. (TSE: 4554) Announce Exclusive Negotiation Agreement

Vistagen (NASDAQ: VTGN) is a clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders. Together with Fuji Pharma Co. (TSE: 4554), a pharmaceutical company ...
VTGN - Vistagen in pact to issue a potential license for hot flashes therapy in Japan

2023-09-05 09:29:57 ET More on VistaGen Seeking Alpha’s Quant Rating on VistaGen Therapeutics Historical earnings data for VistaGen Therapeutics Financial information for VistaGen Therapeutics Vistagen Therapeutics, Inc. ( VTGN ) Q1 2024 Earnings...

VTGN - Vistagen and Fuji Enter Exclusive Negotiation Agreement for a Potential License to Develop and Commercialize Vistagen's Investigational Menopausal Hot Flash Therapy, PH80 Nasal Spray, in Japan

Vistagen to receive $1.5 million and Fuji to obtain time-limited exclusive negotiation period for the Japanese market Recently reported exploratory Phase 2A study in women diagnosed with menopausal hot flashes demonstrated PH80’s statistically significant reduction in the number of...

VTGN - InvestorNewsBreaks - VistaGen Therapeutics Inc. (NASDAQ: VTGN) Appoints Highly Accomplished Finance Professional as CFO

Vistagen (NASDAQ: VTGN) is a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders. The company today announced its appointment of Cindy Anderson a...
VTGN - Vistagen Therapeutics appoints CFO

2023-08-22 08:48:52 ET More on VistaGen Therapeutics Vistagen Therapeutics, Inc. ( VTGN ) Q1 2024 Earnings Call Transcript Vistagen up 905% on phase 3 social anxiety drug results Vistagen posts real world data to highlight hot flashes therapy Seeking Alph...

VTGN - Vistagen Appoints Cindy Anderson as Chief Financial Officer

Anderson succeeds Jerrold Dotson who is retiring after a distinguished decade-long career with Vistagen Vistagen (NASDAQ: VTGN) a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other centr...

VTGN - NKLA, SLI and TUP among pre-market losers

2023-08-14 08:32:23 ET AMC Entertainment Holdings ( AMC ) -33% . BioXcel Therapeutics BTAI -32% after Q2 earning release . Bridgeline Digital BLIN -19% after Q3 earning release . Black Spade Acquisition Co ( BSAQ ) -16% . Fortrea Holdings FT...
VTGN - Vistagen Therapeutics, Inc. (VTGN) Q1 2024 Earnings Call Transcript

2023-08-13 05:24:05 ET Vistagen Therapeutics, Inc. (VTGN) Q1 2024 Earnings Conference Call August 10, 2023, 04:30 PM ET Company Participants Mark Flather - VP of IR Shawn Singh - CEO Josh Prince - SVP of Business Operations Conference Call Participants ...

VTGN - InvestorNewsBreaks - Vistagen Therapeutics Inc. (NASDAQ: VTGN) Releases Q1 2024 Financial Report, Corporate Update

Vistagen Therapeutics (NASDAQ: VTGN) , a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders, is reporting its financial results for the first qua...

VTGN - TGTX, NKTR and AMLI among pre-market losers

2023-08-11 08:16:36 ET Cano Health ( CANO ) -48% after Q2 earning release . Yield10 Bioscience ( YTEN ) -46% . Maxeon Solar Technologies, Ltd. ( MAXN ) -26% after Q2 earning release . LQR House ( LQR ) -17% . Vistagen Therapeutics ( ...
Previous 10 Next 10